Company profile for MSD INTL GMBH

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

The Asia Pacific is a leading growth driver for MSD within the Emerging Markets. Headquartered in Singapore, MSD's Asia Pacific operations span thirteen diverse geographies encompassing Australia, China, Hong Kong, India, Indonesia, the Republic of Korea, Malaysia, New Zealand, Philippines, Singapore, Taiwan, Thailand, and Vietnam. MSD has been present in the Asia Pacific for some 60 years and currently employs about 17,000 p...
The Asia Pacific is a leading growth driver for MSD within the Emerging Markets. Headquartered in Singapore, MSD's Asia Pacific operations span thirteen diverse geographies encompassing Australia, China, Hong Kong, India, Indonesia, the Republic of Korea, Malaysia, New Zealand, Philippines, Singapore, Taiwan, Thailand, and Vietnam. MSD has been present in the Asia Pacific for some 60 years and currently employs about 17,000 people. Over the coming decade, most of the world's pharmaceutical growth will come from the Emerging Markets, including the Asia Pacific. Driving performance in these high-growth markets is a priority for MSD.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Singapore
Address
Address
600 North Bridge, Road #10-01/10 Parkview Square 188778
Telephone
Telephone
+(65) 6305-8400
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

http://www.pharmatimes.com/news/novel_antibiotic_recarbrio_has_launched_in_the_uk_1357341

PHARMATIMES
20 Nov 2020

https://www.business-standard.com/article/international/pharma-companies-committed-to-science-first-policy-on-covid-19-vaccine-120092100149_1.html

BUSINESS STANDARD
21 Sep 2020

https://www.raps.org/news-and-articles/news-articles/2020/1/eu-court-of-justice-rules-in-favor-of-ema-in-trans

Zachary Brennan RAPS
23 Jan 2020
Unichem Labs gets USFDA nod for asthma drug
Unichem Labs gets USFDA nod for asthma drug

04 Jul 2018

// ECONOMIC TIMES

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/unichem-labs-gets-usfda-nod-for-asthma-drug/articleshow/64854672.cms

ECONOMIC TIMES
04 Jul 2018

Inspections and registrations

Upload your audits for free, ask us

ABOUT THIS PAGE

Contact MSD INTL GMBH and get a quotation

MSD INTL GMBH is a supplier offers 7 products (APIs, Excipients or Intermediates).

Find a price of Betamethasone bulk with JDMF offered by MSD INTL GMBH

Find a price of Betamethasone Dipropionate bulk with JDMF offered by MSD INTL GMBH

Find a price of Betamethasone Valerate bulk with JDMF offered by MSD INTL GMBH

Find a price of Mometasone Furoate bulk with JDMF offered by MSD INTL GMBH

Find a price of Montelukast Sodium bulk with JDMF offered by MSD INTL GMBH

Find a price of Sitagliptin Phosphate bulk with JDMF offered by MSD INTL GMBH

Find a price of Loratadine bulk offered by MSD INTL GMBH

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty